What is the current Non-Invasive Prenatal DNA Testing Service market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Non-Invasive Prenatal DNA Testing Service market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the major challenges facing the Non-Invasive Prenatal DNA Testing Service market?

High costs and regulatory hurdles are significant challenges in the market.

Which regions are leading the Non-Invasive Prenatal DNA Testing Service market?

North America and Europe are currently the leading regions in the market.

Who are the top companies in the Non-Invasive Prenatal DNA Testing Service market?

Illumina, Roche, and Quest Diagnostics are among the top companies in the market.

What future opportunities exist in the Non-Invasive Prenatal DNA Testing Service market?

Expanding into emerging markets and developing new technologies are future opportunities.

How is technology impacting the Non-Invasive Prenatal DNA Testing Service market?

Advances in sequencing and analysis technologies are improving test accuracy and efficiency.

What is the current regulatory landscape for the Non-Invasive Prenatal DNA Testing Service market?

Regulations vary by region, but most countries have guidelines for test approval and use.

What is the future outlook for the Non-Invasive Prenatal DNA Testing Service market?

The market is expected to continue growing, driven by advances in technology and increasing demand.

Non-Invasive Prenatal DNA Testing Service Market Metrics & Forecast Analysis 2033

Non-Invasive Prenatal DNA Testing Service by Application (Hospitals, Medical Institutions, Others), by Types (Serum Biochemical Index Detection, Maternal Peripheral Blood Free DNA Detection, Ultrasound Screening), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Non-Invasive Prenatal DNA Testing Service Market Size | CAGR 12.1 Forecast 2033

Non-Invasive Prenatal DNA Testing Service Market Metrics & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Non-Invasive Prenatal DNA Testing Service Market Overview

The Non-Invasive Prenatal DNA Testing Service market refers to the industry that provides prenatal testing services using non-invasive methods, such as cell-free DNA testing. The Non-Invasive Prenatal DNA Testing Service market size is estimated to be around $1.4 billion in 2025. As the industry continues to expand, the growth outlook and market forecast indicate a significant increase in demand for these services, driven by advances in technology and increasing awareness of prenatal testing. The market forecast suggests a compound annual growth rate (CAGR) of 10.2% from 2026 to 2033, with key drivers including technology shifts, regulatory approvals, and changing consumer behavior.

Loading chart…

The largest region for the Non-Invasive Prenatal DNA Testing Service market is North America, driven by high awareness and advanced healthcare infrastructure. The fastest-growing region is expected to be Asia-Pacific, driven by increasing demand and expanding healthcare access. Key forces shaping the industry include technological advancements, regulatory frameworks, and competitive intensity. As the market continues to evolve, it is essential for industry players to stay informed about the latest trends and developments to remain competitive. The Non-Invasive Prenatal DNA Testing Service market is expected to experience significant growth, driven by increasing adoption and expanding applications, with the global market forecast to reach $2.6 billion by 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.99 billion
Growth rate	CAGR of 12.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Natera Inc; Illumina; Roche; GE Healthcare; Thermo Fisher Scientific; PerkinElmer; Qiagen; Agilent Technologies; Veritas; BGI Group; Annoroad
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Non-Invasive Prenatal DNA Testing Service market is poised for significant growth, driven by advancements in technology and increasing demand for prenatal testing. Understanding the market dynamics is crucial for stakeholders to navigate this complex landscape.

Growth Drivers2 items

Advances in next-generation sequencing and bioinformatics are enhancing the accuracy and reliability of Non-Invasive Prenatal DNA Testing Services, driving growth in the market size and contributing to a promising growth forecast.

Increasing awareness about the benefits of non-invasive prenatal testing among expectant mothers, particularly in developed economies, is fueling the demand for these services and expanding the Non-Invasive Prenatal DNA Testing Service market.

Restraints2 items

High costs associated with Non-Invasive Prenatal DNA Testing Services, coupled with limited reimbursement options, may hinder market growth and affect the growth forecast of the Non-Invasive Prenatal DNA Testing Service market size.

Stringent regulatory frameworks and varying standards of practice across different regions may restrict the adoption of Non-Invasive Prenatal DNA Testing Services and impact the overall Non-Invasive Prenatal DNA Testing Service market.

Opportunities2 items

Emerging economies present significant opportunities for the expansion of Non-Invasive Prenatal DNA Testing Services, driven by increasing healthcare expenditure and a growing demand for advanced prenatal testing, which is expected to contribute to the growth forecast of the Non-Invasive Prenatal DNA Testing Service market size.

Integration of artificial intelligence and machine learning in Non-Invasive Prenatal DNA Testing Services can enhance their accuracy and efficiency, providing a competitive edge to market players and influencing the Non-Invasive Prenatal DNA Testing Service market.

Challenges2 items

Ensuring the privacy and security of sensitive genetic data remains a significant challenge for providers of Non-Invasive Prenatal DNA Testing Services, affecting consumer trust and the overall Non-Invasive Prenatal DNA Testing Service market size.

The Non-Invasive Prenatal DNA Testing Service market faces challenges from intense competition and pricing pressures, which can impact profit margins and the growth forecast of market players.

Market Segmentation

Loading chart…

The Non-Invasive Prenatal DNA Testing Service segmentation by application refers to the categorization of the market based on the purpose or use of the testing services. This includes prenatal screening for chromosomal abnormalities, prenatal diagnosis for detecting specific genetic conditions, and prenatal testing for determining the sex of the fetus. Each application segment contributes to the overall market size, with prenatal screening being the largest segment due to the increasing demand for non-invasive tests that can detect genetic disorders early in pregnancy.

The Non-Invasive Prenatal DNA Testing Service market can be segmented by types into cell-free DNA (cfDNA) testing and non-invasive prenatal testing (NIPT) using next-generation sequencing (NGS). The cfDNA testing segment dominates the market due to its high sensitivity and specificity in detecting fetal DNA in the mother's blood. The NIPT segment using NGS is expected to grow rapidly due to its ability to detect multiple genetic conditions and its increasing adoption in clinical practice. Understanding these segments is crucial for market taxonomy and analyzing the growth prospects of the Non-Invasive Prenatal DNA Testing Service market.

Non-Invasive Prenatal DNA Testing Service Segmentation Breakdown8 items

Application

Hospitals

Medical Institutions

Others

Types

Serum Biochemical Index Detection

Maternal Peripheral Blood Free DNA Detection

Ultrasound Screening

Regional Insights

Loading chart…

The Non-Invasive Prenatal DNA Testing Service market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of non-invasive prenatal testing, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include high ecosystem maturity, increasing demographics of expectant mothers, and growing awareness of non-invasive prenatal testing. In Europe, key drivers include favorable regulatory policies, infrastructure development, and rising demand for non-invasive prenatal testing. Asia Pacific is driven by government initiatives, increasing access to healthcare, and a large target population. Latin America and Middle East & Africa are driven by growing awareness, increasing healthcare expenditure, and improving infrastructure.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by emerging economies such as China and India. The Non-Invasive Prenatal DNA Testing Service market growth in Latin America and Middle East & Africa will be driven by increasing adoption of non-invasive prenatal testing and improving healthcare infrastructure.

Competitive Landscape

The Non-Invasive Prenatal DNA Testing Service market exhibits a moderately consolidated structure, driven by a mix of global players and local companies. The Non-Invasive Prenatal DNA Testing Service competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on technological advancements and strategic partnerships to expand their market presence, while local companies concentrate on regional expansion and customization to cater to specific market needs.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to differentiate themselves and gain a competitive edge. Common differentiation strategies include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, and commoditization. Key players are adapting to these challenges by focusing on innovation, premium pricing, and strengthening their distribution networks.

Natera Inc: innovation pipeline

Illumina: premium pricing

Roche: regional expansion

GE Healthcare: vertical integration

Thermo Fisher Scientific: OEM tie-ups

PerkinElmer: local manufacturing

Key Non-Invasive Prenatal DNA Testing Service Companies11 items

Natera Inc

Illumina

Roche

GE Healthcare

Thermo Fisher Scientific

PerkinElmer

Qiagen

Agilent Technologies

Veritas

BGI Group

Annoroad

Market Ecosystem

The Non-Invasive Prenatal DNA Testing Service ecosystem encompasses a complex network of upstream, midstream, and downstream participants. Upstream, technology providers and suppliers deliver essential components and expertise, while midstream integrators and channels facilitate the development and distribution of testing services. Downstream, end users, including expectant parents and healthcare providers, ultimately receive and utilize these services, creating and capturing value within the ecosystem.

Technology providers — develop testing methodologies

Raw material/component suppliers — provide sampling kits

System integrators / EPCs — integrate testing services

Distributors / channel partners — facilitate service delivery

Service providers / after-sales — offer support and counseling

Regulators/standards bodies — establish testing guidelines

Data/analytics providers — interpret testing results

Within the Non-Invasive Prenatal DNA Testing Service ecosystem, control points, such as regulatory approvals and reimbursement policies, influence adoption and utilization of these services. Dependency risks, including input constraints and standards compliance, can also impact the ecosystem's functioning. Furthermore, switching costs, partnerships, and interoperability requirements can affect the relationships between ecosystem participants. As the ecosystem differs by region, due to varying regulatory frameworks and healthcare systems, a thorough value chain analysis is necessary to understand the intricacies of this complex ecosystem.

Recent Industry Insights

The Non-Invasive Prenatal DNA Testing Service industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have led to the expansion of services, improving accessibility for expectant parents. Notable mergers and acquisitions have also taken place, resulting in the consolidation of market share and enhanced technological capabilities. Furthermore, innovative product launches have enabled more accurate and comprehensive testing, driving growth in the industry.

Additionally, regulatory changes have paved the way for increased adoption of non-invasive prenatal DNA testing, with a shift in consumer trends towards more informed reproductive choices. The industry has also seen substantial funding rounds and expansions, underscoring its potential for continued growth and innovation. As the demand for non-invasive prenatal DNA testing continues to rise, the industry is poised to evolve, driven by advancing technologies and changing consumer needs, ultimately shaping the future of prenatal care.

Analyst Overview

As the Lead Analyst for this study, I can conclude that the Non-Invasive Prenatal DNA Testing Service market outlook is highly attractive, driven by increasing demand for safe and accurate prenatal testing. The competitive intensity in this market is moderate, with key players investing heavily in research and development to improve test accuracy and expand their product offerings.

The long-term outlook for this market is positive, with innovations in next-generation sequencing and artificial intelligence expected to drive growth. However, the demand-supply balance may be affected by key risk factors such as regulatory changes and reimbursement issues. Overall, the Non-Invasive Prenatal DNA Testing Service market is expected to experience significant growth, driven by advancements in technology and increasing awareness among expectant parents.

11 items

1. Executive Summary

2. Non-Invasive Prenatal DNA Testing Service Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Non-Invasive Prenatal DNA Testing Service Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Non-Invasive Prenatal DNA Testing Service Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Medical Institutions

6.1.3. Others

6.2. Global Non-Invasive Prenatal DNA Testing Service Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Serum Biochemical Index Detection

6.2.2. Maternal Peripheral Blood Free DNA Detection

6.2.3. Ultrasound Screening

6.3. Global Non-Invasive Prenatal DNA Testing Service Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Non-Invasive Prenatal DNA Testing Service Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Non-Invasive Prenatal DNA Testing Service Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Non-Invasive Prenatal DNA Testing Service Market Competition by Key Manufacturers

8.1. Global Non-Invasive Prenatal DNA Testing Service Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Non-Invasive Prenatal DNA Testing Service: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Natera Inc

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Illumina

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Roche

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. GE Healthcare

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Thermo Fisher Scientific

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. PerkinElmer

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Qiagen

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Agilent Technologies

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Veritas

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. BGI Group

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Annoroad

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Non-Invasive Prenatal DNA Testing Service Market

Figure 4: Global Non-Invasive Prenatal DNA Testing Service Market: Drivers

Figure 5: Global Non-Invasive Prenatal DNA Testing Service Market: Challenges

Figure 6: Global Non-Invasive Prenatal DNA Testing Service Market: Trends

Figure 7: Global Non-Invasive Prenatal DNA Testing Service Market: Opportunity

Figure 8: Global Non-Invasive Prenatal DNA Testing Service Market: Restraint

Figure 9: Global Non-Invasive Prenatal DNA Testing Service Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Non-Invasive Prenatal DNA Testing Service Market Value (USD Million) By Region

Figure 15: Global Non-Invasive Prenatal DNA Testing Service Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Non-Invasive Prenatal DNA Testing Service Market Value (USD Million) By Region

Figure 23: Global Non-Invasive Prenatal DNA Testing Service Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Non-Invasive Prenatal DNA Testing Service Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Non-Invasive Prenatal DNA Testing Service Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Non-Invasive Prenatal DNA Testing Service Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Non-Invasive Prenatal DNA Testing Service Market Value (USD Million) By Region

Table 10: Global Non-Invasive Prenatal DNA Testing Service Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Non-Invasive Prenatal DNA Testing Service Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Non-Invasive Prenatal DNA Testing Service Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Non-Invasive Prenatal DNA Testing Service Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Natera Inc Basic Information And Sales Area

Table 31: Natera Inc. Products Portfolio

Table 32: Illumina Basic Information And Sales Area

Table 33: Illumina. Products Portfolio

Table 34: Roche Basic Information And Sales Area

Table 35: Roche. Products Portfolio

Table 36: GE Healthcare Basic Information And Sales Area

Table 37: GE Healthcare. Products Portfolio

Table 38: Thermo Fisher Scientific Basic Information And Sales Area

Table 39: Thermo Fisher Scientific. Products Portfolio

Table 40: PerkinElmer Basic Information And Sales Area

Table 41: PerkinElmer. Products Portfolio

Table 42: Qiagen Basic Information And Sales Area

Table 43: Qiagen. Products Portfolio

Table 44: Agilent Technologies Basic Information And Sales Area

Table 45: Agilent Technologies. Products Portfolio

Table 46: Veritas Basic Information And Sales Area

Table 47: Veritas. Products Portfolio

Table 48: BGI Group Basic Information And Sales Area

Table 49: BGI Group. Products Portfolio

Table 50: Annoroad Basic Information And Sales Area

Table 51: Annoroad. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Non-Invasive Prenatal DNA Testing Service Market Value (USD Million) By Region

Table 57: Global Non-Invasive Prenatal DNA Testing Service Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Non-Invasive Prenatal DNA Testing Service Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.99 billion
Growth rate	CAGR of 12.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Natera Inc; Illumina; Roche; GE Healthcare; Thermo Fisher Scientific; PerkinElmer; Qiagen; Agilent Technologies; Veritas; BGI Group; Annoroad
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options